文献速递中毒与环境急症消化、代谢与肾脏急症

无家可归成人的非法物质使用与治疗可及性

Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness.
PubMed 文献 · JAMA · 2025-01-01
一句话结论在加州8县代表性调查中,无家可归成人过去6个月定期使用非法药物者占37.1%,21.2%有治疗需求未满足,作者认为应改善针对该人群的治疗可及性。

该研究于2021年10月至2022年11月在加州8个县采用多阶段概率抽样和受访者驱动抽样,对符合联邦无家可归定义的18岁及以上成人进行代表性调查,共3200人参与。结果显示,估计65.3%终生曾定期使用非法药物,37.1%过去6个月定期使用任何药物(甲基苯丙胺33.1%、阿片类10.4%、可卡因3.2%);终生非致命性过量19.6%,目前持有纳洛酮24.9%。在有终生定期使用的人群中,仅6.7%目前在接受治疗;过去6个月有定期使用的人群中,21.2%希望但未获得治疗。作者认为,改善针对无家可归者需求的治疗可及性可能改善结局。

要点

  • 在3200名无家可归成人中,估计37.1%(95%CI 32.9%-41.3%)过去6个月定期使用任何非法药物,其中甲基苯丙胺33.1%(95%CI 29.4%-36.7%)、阿片类10.4%(95%CI 7.9%-12.9%)、可卡因3.2%(95%CI 1.8%-4.6%)。
  • 估计19.6%(95%CI 17.4%-21.8%)终生发生过非致命性过量,目前持有纳洛酮者仅24.9%(95%CI 21.3%-28.5%)。
  • 在有终生定期使用的人群中,仅6.7%(95%CI 3.8%-9.5%)目前在接受治疗;过去6个月有定期使用的人群中,21.2%(95%CI 17.9%-24.5%)希望但未获得治疗。
  • 估计65.3%(95%CI 62.2%-68.4%)终生曾定期使用非法药物,其中41.6%(95%CI 39.4%-43.8%)在首次无家可归前开始定期使用,23.2%(95%CI 20.5%-25.9%)在之后开始。
  • 估计25.6%(95%CI 22.8%-28.3%)终生注射过药物,11.8%(95%CI 9.8%-13.8%)过去6个月注射过药物。

适用人群与场景

  • 美国加州8个县、2021年10月至2022年11月、18岁及以上且符合联邦无家可归定义的成人。

研究设计与关键结果

  • 代表性调查研究:2021年10月至2022年11月在加州8个县采用多阶段概率抽样和受访者驱动抽样,3865人被接触,3042人(79%)参与,另通过受访者驱动抽样招募158人,共纳入3200人。
  • 参与者平均年龄46.1岁(95%CI 45.3-46.9),67.3%(95%CI 65.2%-69.3%)为顺性别男性,黑人和非洲裔美国人、西班牙裔和拉丁裔、白人参与者比例相近。
  • 估计65.3%(95%CI 62.2%-68.4%)终生曾定期(每周≥3次)使用非法药物;41.6%(95%CI 39.4%-43.8%)在首次无家可归前开始定期使用,23.2%(95%CI 20.5%-25.9%)在之后开始。
  • 过去6个月,估计37.1%(95%CI 32.9%-41.3%)定期使用任何药物;甲基苯丙胺33.1%(95%CI 29.4%-36.7%)、阿片类10.4%(95%CI 7.9%-12.9%)、可卡因3.2%(95%CI 1.8%-4.6%)。
  • 估计25.6%(95%CI 22.8%-28.3%)终生注射过药物,11.8%(95%CI 9.8%-13.8%)过去6个月注射过药物。
  • 在有终生定期使用的人群中,估计6.7%(95%CI 3.8%-9.5%)目前在接受治疗;在过去6个月有定期使用的人群中,估计21.2%(95%CI 17.9%-24.5%)希望但未获得治疗。
  • 估计19.6%(95%CI 17.4%-21.8%)终生发生过非致命性过量,24.9%(95%CI 21.3%-28.5%)目前持有纳洛酮。

证据类型、等级与局限

  • 证据类型:代表性调查研究(多阶段概率抽样和受访者驱动抽样)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,改善针对无家可归者需求的治疗可及性可能改善结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The lack of representative research on homelessness risks mischaracterizing and misrepresenting the prevalence of illicit substance use.

OBJECTIVE: To estimate the population prevalence and patterns of illicit substance use, treatment, nonfatal overdose, and naloxone possession among people experiencing homelessness in 1 US state.

DESIGN, SETTING, AND PARTICIPANTS: This representative survey study of adults experiencing homelessness from October 2021 to November 2022 in 8 California counties used multistaged probability-based sampling and respondent-driven sampling. Eligible individuals were 18 years or older and met the federal definition of homelessness.

MAIN OUTCOMES AND MEASURES: The primary outcome measures included lifetime and past-6-month illicit substance use and substance type (methamphetamine, nonprescription opioids, or cocaine). Lifetime and current substance use treatment, unmet treatment need, types of treatments received, nonfatal overdose (lifetime and current episode of homelessness), and current possession of naloxone were measured. Population prevalence estimates with 95% Wald CIs were calculated using survey replicate weights.

RESULTS: Of 3865 individuals approached, 3042 (79%) participated and an additional 158 participants were recruited through respondent-driven sampling. Among 3200 participants, the mean age was 46.1 (95% CI, 45.3-46.9) years, 67.3% (95% CI, 65.2%-69.3%) were cisgender male, and there were similar proportions of Black and African American, Hispanic and Latine, and White participants. Overall, an estimated 65.3% (95% CI, 62.2%-68.4%) of participants used illicit drugs regularly (≥3 times per week) in their lifetime; 41.6% (95% CI, 39.4%-43.8%) began using regularly before their first episode of homelessness and 23.2% (95% CI, 20.5%-25.9%) began using regularly after. In the past 6 months, an estimated 37.1% (95% CI, 32.9%-41.3%) of participants reported regular use of any drug; 33.1% (95% CI, 29.4%-36.7%) reported use of methamphetamines, 10.4% (95% CI, 7.9%-12.9%) reported use of opioids, and 3.2% (95% CI, 1.8%-4.6%) reported use of cocaine. In their lifetime, an estimated 25.6% (95% CI, 22.8%-28.3%) injected drugs and 11.8% (95% CI, 9.8%-13.8%) injected drugs in the past 6 months. Among those with any regular lifetime use, an estimated 6.7% (95% CI, 3.8%-9.5%) of participants were currently receiving treatment. Of those with any regular use in the last 6 months, an estimated 21.2% (95% CI, 17.9%-24.5%) reported currently wanting but not receiving treatment. An estimated 19.6% (95% CI, 17.4%-21.8%) of participants had a nonfatal overdose in their lifetime and 24.9% (95% CI, 21.3%-28.5%) currently possessed naloxone.

CONCLUSION AND RELEVANCE: In a representative study of adults experiencing homelessness in California, there was a high proportion of current drug use, history of overdose, and unmet need for treatment. Improving access to treatment tailored to the needs of people experiencing homelessness could improve outcomes.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Assaf RD, Morris MD, Straus ER, et al. Illicit Substance Use and Treatment Access Among Adults Experiencing Homelessness. JAMA. 2025. PMID: 39969877. doi:10.1001/jama.2024.27922

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。